KBC Group’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
Other funds holding NVAX
KBC Group's NVAX Position: Q3 2026 in Review
KBC Group held its Novavax (NVAX) position steady in Q3 2026 at 4,746 shares worth $51K. The position accounts for ﹤0.01% of the portfolio, ranked #1717.
KBC Group first reported a position in NVAX in Q2 2021 and has held it in 17 quarters since. The position peaked at $1.21M in Q2 2021. 203 funds tracked by Wall St. Rank hold NVAX as of Q3 2026.
- KBC Group held 4,746 shares of Novavax worth $51K as of Q3 2026.
- KBC Group left its Novavax share count unchanged in Q3 2026.
- Novavax made up ﹤0.01% of KBC Group's portfolio in Q3 2026, its #1717 holding.
- KBC Group first reported a position in Novavax in Q2 2021 and has held it in 17 quarters since.
- KBC Group's Novavax position peaked at $1.21M in Q2 2021.
- 203 funds tracked by Wall St. Rank held Novavax as of Q3 2026.
Based on KBC Group's 13F filing for Q3 2026, filed 22 Oct 2026.